|
|
(March 21, 2025) – Yesterday and today, the Senate took final action on the bills included in this article.
|
|
|
|
(March 21, 2025) – Thursday saw the first conference committee meeting of the House Appropriations Committee leadership and the Senate Ways and Means Committee leadership.
|
|
|
|
(March 21, 2025) – Next week, House and Senate Conference Committees will meet. Bills will begin being packaged together and run across chamber floors for final votes by the House and Senate before the April break when the legislature heads home ahead of the veto session scheduled for April 10.
|
|
|
|
(March 18, 2025) – Today, the Senate Financial Institutions and Insurance Committee took action to amend SB 284, to take out the pharmaceutical manufacturer wholesalers.
|
|
|
|
(March 18, 2025) – Today, the Senate Public Health and Welfare Committee held a hearing on HB 2217 and worked HB 2039, HB 2311 and HB 2335.
|
|
|
|
(March 18, 2025) – Today, the House and Senate took final action votes and debated bills before them.
|
|
|
|
(March 17, 2025) – Today, the Senate Financial Institutions and Insurance Committee held a hearing on Senate Bill 284, the legislation would ensure that drug manufacturers cannot limit contract pharmacies or ask for additional data from 340B entities than other contracted locations.
|
|
|
|
(March 17, 2025) – Today, the Senate Ways and Means Committee held hearings on HB 2195, HB 2221, SB 290 and SCR 1612.
|
|
|
|
(March 17, 2025) – Today, the full House took final votes on SB 194, SB 27, SB 28, SB 32, SB 42, SB 139 and SB 166. The House debated SB 50, SB 78, HB 2402, SB 114, and Sub for HB 2012.
|
|
|
|
(March 17, 2025) – Today, the Senate Federal and State Affairs Committee narrowly voted down SB 196.
|
|
|